Literature DB >> 20132811

Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart.

Li-Zhen Yang1, Philip Tovote, Martin Rayner, Jens Kockskämper, Burkert Pieske, Joachim Spiess.   

Abstract

Corticotropin-releasing factor (CRF), a 41 amino acid peptide, was discovered as a key signal in mediating neuroendocrine, autonomic, and behavioral responses to stress. It was revealed later that there exist additional CRF-like peptides, termed urocortins. The CRF receptor subtype 1 (CRF1 receptor) is predominant in the brain whereas subtype 2 (CRF2 receptor) is highly expressed in the brain and the heart. Both centrally and peripherally administered CRF and urocortins produce significant hemodynamic effects via activation of CRF receptors in the brain and the heart. CRF and urocortins are important neural and cardioactive hormones, and are potentially useful therapy for heart failure. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20132811     DOI: 10.1016/j.ejphar.2010.01.027

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

1.  Urocortin 3 elevates cytosolic calcium in nucleus ambiguus neurons.

Authors:  G Cristina Brailoiu; Elena Deliu; Andrei A Tica; Vineet C Chitravanshi; Eugen Brailoiu
Journal:  J Neurochem       Date:  2012-08-03       Impact factor: 5.372

2.  An integrated map of corticotropin-releasing hormone signaling pathway.

Authors:  Tejaswini Subbannayya; Lavanya Balakrishnan; Granthali Sudarshan; Jayshree Advani; Santosh Kumar; Riaz Mahmood; Bipin Nair; Ravi Sirdeshmukh; Kanchan K Mukherjee; Sudhir N Umathe; Rajesh Raju; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2013-03-16       Impact factor: 5.782

Review 3.  Structure of Class B GPCRs: new horizons for drug discovery.

Authors:  Andrea Bortolato; Andrew S Doré; Kaspar Hollenstein; Benjamin G Tehan; Jonathan S Mason; Fiona H Marshall
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

4.  Structural basis for hormone recognition by the Human CRFR2{alpha} G protein-coupled receptor.

Authors:  Kuntal Pal; Kunchithapadam Swaminathan; H Eric Xu; Augen A Pioszak
Journal:  J Biol Chem       Date:  2010-10-21       Impact factor: 5.157

5.  Urocortin 1 reduces food intake and ghrelin secretion via CRF(2) receptors.

Authors:  Koji Yakabi; Masamichi Noguchi; Shino Ohno; Shoki Ro; Tsuneko Onouchi; Mitsuko Ochiai; Hidehiko Takabayashi; Kiyoshige Takayama; Yumi Harada; Chiharu Sadakane; Tomohisa Hattori
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-03       Impact factor: 4.310

6.  cAMP- and Ca²(+) /calmodulin-dependent protein kinases mediate inotropic, lusitropic and arrhythmogenic effects of urocortin 2 in mouse ventricular myocytes.

Authors:  Li-Zhen Yang; Jens Kockskämper; Shelina Khan; Jorge Suarez; Stefanie Walther; Bernhard Doleschal; Gregor Unterer; Mounir Khafaga; Heinrich Mächler; Frank R Heinzel; Wolfgang H Dillmann; Burkert Pieske; Joachim Spiess
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

7.  Urocortin 2 stimulates nitric oxide production in ventricular myocytes via Akt- and PKA-mediated phosphorylation of eNOS at serine 1177.

Authors:  Stefanie Walther; Florentina Pluteanu; Susanne Renz; Yulia Nikonova; Joshua T Maxwell; Li-Zhen Yang; Kurt Schmidt; Joshua N Edwards; Paulina Wakula; Klaus Groschner; Lars S Maier; Joachim Spiess; Lothar A Blatter; Burkert Pieske; Jens Kockskämper
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-11       Impact factor: 4.733

8.  Corticotropin-releasing factor (CRF) receptor-1 is involved in cardiac noradrenergic activity observed during naloxone-precipitated morphine withdrawal.

Authors:  Elena Martínez-Laorden; Juan-Antonio García-Carmona; Alberto Baroja-Mazo; Paola Romecín; Noemí M Atucha; María-Victoria Milanés; María-Luisa Laorden
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 9.  Key role of CRF in the skin stress response system.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Blazej Zbytek; Desmond J Tobin; Theoharis C Theoharides; Jean Rivier
Journal:  Endocr Rev       Date:  2013-08-12       Impact factor: 19.871

10.  Ghrelin enhancer, rikkunshito, improves postprandial gastric motor dysfunction in an experimental stress model.

Authors:  Y Harada; S Ro; M Ochiai; K Hayashi; E Hosomi; N Fujitsuka; T Hattori; K Yakabi
Journal:  Neurogastroenterol Motil       Date:  2015-06-18       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.